An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report
An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: A sequenced treatment alternatives to relieve depression trial report
复制标题
DOI：
10.1016/j.biopsych.2005.08.022
复制
发表时间：
2006-03-15
影响因子：
10.6
通讯作者：
Fava, M
中科院分区：
文献类型：
--
作者：
Rush, AJ;Bernstein, IH;Fava, M
背景9个DSM-IV-TR标准症状域被评估以诊断重性抑郁障碍（MDD）。抑郁症状快速量表（QIDS）提供了对这些领域的有效评估，并可作为临床医生评级（QIDS-C-16），自我报告（QIDS-SR 16）和自动交互式语音应答（IVR）（QIDS-IVR 16）电话系统。本报告比较了这三个版本的QIDS和17项汉密尔顿抑郁量表（HRSD 17）的表现。在基线和退出第一个治疗步骤时采集数据（西酞普兰）在缓解抑郁症的序贯治疗替代方案（星星 *D）试验中，从最初的1500名星星 *D受试者中识别出在+/- 2天内完成所有四项评定的非精神病性MDD门诊患者。项目反应理论和经典测验理论。结果：获得QIDS数据的三种方法产生了一致的结果，9个症状域和整体抑郁症之间的关系，证明三种方法之间的可比较性。HRSD 17，而一般令人满意的，很少利用全方位的项目得分，证据表明多维测量properties.Conclusions：在非精神病性MDD门诊患者没有明显的认知功能障碍，临床医生评估抑郁症的严重程度使用QIDS-C-16或HRSD 17可以成功地取代自我报告或IVR版本的QIDS。
Background. Nine DSM-IV-TR criterion symptom domains are evaluated to diagnose major depressive disorder (MDD). The Quick Inventory of Depressive Symptomatology (QIDS) provides an efficient assessment of these domains and is available as a clinician rating (QIDS-C-16), a self-report (QIDS-SR16), and in an automated, interactive voice response (IVR) (QIDS-IVR16) telephone system. This report compares the performance of these three versions of the QIDS and the 17-item Hamilton Rating Scale for Depression (HRSD17).Methods: Data were acquired at baseline and exit from the first treatment step (citalopram) in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial, Outpatients with nonpsychotic MDD who completed all four ratings within +/- 2 days were identified from the first 1500 STAR*D subjects. Both item response theory and classical test theory. analyses were conducted.Results: The three methods for obtaining QIDS data produced consistent findings regarding relationships between the nine symptom domains and overall depression, demonstrating interchangeability among the three methods. The HRSD17 while generally satisfactory, rarely utilized the full range of item scores, and evidence suggested multidimensional measurement properties.Conclusions: In nonpsychotic MDD outpatients without overt cognitive impairment, clinician assessment of depression severity using either the QIDS-C-16 or HRSD17 may be successfully replaced by either the self-report or lVR version of the QIDS.